The Food and Drug Administration very first accredited the injectable medication for treating diabetes in 2017; the agency authorised a drug with a higher dose on the Lively ingredient in copyright, called semaglutide, to take care of obesity in 2021, beneath the manufacturer name Wegovy. Since then, converse of the drug has popped up across the on